Repligen, a bioprocessing company, agreed to acquire ARTeSYN Biosolutions, a biotechnology equipment manufacturer, for $130m. “We have made tremendous progress over the last four years as we introduced automated, highly efficient chromatography and filtration systems with unique flow path designs. We are at a point now where we need to scale again and believe Repligen is the best partner to grow with. We look forward to driving expanded, global adoption of our products, and continuing to advance innovative single-use systems and flow paths as gold standards in the industry," Michael Gagne, ARTeSYN Biosolutions Founder and CXO.